Title: Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function.
Journal: Psychopharmacology 20110101
Title: Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
Journal: Anesthesiology 20100301
Title: Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial.
Journal: Stroke 20071001
Title: Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke.
Journal: Neurology 20070313
Title: Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20060101
Title: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia.
Journal: Annals of neurology 20050801
Title: Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies.
Journal: Stroke 20050501
Title: CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
Journal: Journal of medicinal chemistry 20050224
Title: Poststroke neurological improvement within 7 days is associated with subsequent deterioration.
Journal: Stroke 20040901
Title: Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial.
Journal: Stroke 20040601
Title: The rise and fall of NMDA antagonists for ischemic stroke.
Journal: Current molecular medicine 20040301
Title: Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial.
Journal: Stroke 20031001
Title: Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20030401
Title: Stroke Impact Scale-16: A brief assessment of physical function.
Journal: Neurology 20030128
Title: Health care resource use and stroke outcome. Multinational comparisons within the GAIN International trial.
Journal: International journal of technology assessment in health care 20030101
Title: The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects.
Journal: Behavioural pharmacology 20021101
Title: Physicochemical study of the solid forms of a new drug.
Journal: Journal of pharmaceutical sciences 20011201
Title: Synthesis and pharmacological characterisation of a conformationally restrained series of indole-2-carboxylates as in vivo potent glycine antagonists.
Journal: Farmaco (Societa chimica italiana : 1989) 20011001
Title: The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging.
Journal: European journal of pharmacology 20010511
Title: Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.
Journal: JAMA 20010404
Title: Neuroprotection in acute ischemic stroke.
Journal: JAMA 20010404
Title: Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
Journal: British journal of pharmacology 20010401
Title: Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20010101
Title: Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists.
Journal: British journal of pharmacology 20000501
